These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 22692639

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer.
    Liu H, Zhu L, Liu B, Yang L, Meng X, Zhang W, Ma Y, Xiao H.
    Cancer Lett; 2012 Mar 28; 316(2):196-203. PubMed ID: 22169097
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma.
    Fang C, Zhu DX, Dong HJ, Zhou ZJ, Wang YH, Liu L, Fan L, Miao KR, Liu P, Xu W, Li JY.
    Ann Hematol; 2012 Apr 28; 91(4):553-9. PubMed ID: 21987025
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Identification of recurrence-related microRNAs in the bone marrow of breast cancer patients.
    Ota D, Mimori K, Yokobori T, Iwatsuki M, Kataoka A, Masuda N, Ishii H, Ohno S, Mori M.
    Int J Oncol; 2011 Apr 28; 38(4):955-62. PubMed ID: 21271219
    [Abstract] [Full Text] [Related]

  • 13. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis.
    Xu J, Wu C, Che X, Wang L, Yu D, Zhang T, Huang L, Li H, Tan W, Wang C, Lin D.
    Mol Carcinog; 2011 Feb 28; 50(2):136-42. PubMed ID: 21229610
    [Abstract] [Full Text] [Related]

  • 14. Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer.
    Tang D, Shen Y, Wang M, Yang R, Wang Z, Sui A, Jiao W, Wang Y.
    Eur J Cancer Prev; 2013 Nov 28; 22(6):540-8. PubMed ID: 23462458
    [Abstract] [Full Text] [Related]

  • 15. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.
    Gao W, Yu Y, Cao H, Shen H, Li X, Pan S, Shu Y.
    Biomed Pharmacother; 2010 Jul 28; 64(6):399-408. PubMed ID: 20363096
    [Abstract] [Full Text] [Related]

  • 16. Relationship between tumor markers CEA and CA 15-3, TNM staging, estrogen receptor rate and MIB-1 index in patients with pT1-2 breast cancer.
    Lumachi F, Basso SM, Brandes AA, Pagano D, Ermani M.
    Anticancer Res; 2004 Jul 28; 24(5B):3221-4. PubMed ID: 15510614
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis.
    Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, Zeng YX, Shao JY.
    RNA; 2008 Nov 28; 14(11):2348-60. PubMed ID: 18812439
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer.
    Zeng RC, Zhang W, Yan XQ, Ye ZQ, Chen ED, Huang DP, Zhang XH, Huang GL.
    Med Oncol; 2013 Mar 28; 30(1):477. PubMed ID: 23389917
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.